Your browser doesn't support javascript.
A new framework for host-pathogen interaction research.
Yu, Hong; Li, Li; Huffman, Anthony; Beverley, John; Hur, Junguk; Merrell, Eric; Huang, Hsin-Hui; Wang, Yang; Liu, Yingtong; Ong, Edison; Cheng, Liang; Zeng, Tao; Zhang, Jingsong; Li, Pengpai; Liu, Zhiping; Wang, Zhigang; Zhang, Xiangyan; Ye, Xianwei; Handelman, Samuel K; Sexton, Jonathan; Eaton, Kathryn; Higgins, Gerry; Omenn, Gilbert S; Athey, Brian; Smith, Barry; Chen, Luonan; He, Yongqun.
  • Yu H; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital and National Health Commission (NHC) Key Laboratory of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang, Guizhou, China.
  • Li L; Department of Basic Medicine, Guizhou University Medical College, Guiyang, Guizhou, China.
  • Huffman A; Department of Genetics, Harvard Medical School, Boston, MA, United States.
  • Beverley J; University of Michigan Medical School, Ann Arbor, MI, United States.
  • Hur J; Department of Philosophy, University at Buffalo, Buffalo, NY, United States.
  • Merrell E; Asymmetric Operations Sector, Johns Hopkins University Applied Physics Laboratory, Laurel, MD, United States.
  • Huang HH; Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, United States.
  • Wang Y; Department of Philosophy, University at Buffalo, Buffalo, NY, United States.
  • Liu Y; University of Michigan Medical School, Ann Arbor, MI, United States.
  • Ong E; Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Cheng L; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital and National Health Commission (NHC) Key Laboratory of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang, Guizhou, China.
  • Zeng T; Department of Basic Medicine, Guizhou University Medical College, Guiyang, Guizhou, China.
  • Zhang J; University of Michigan Medical School, Ann Arbor, MI, United States.
  • Li P; University of Michigan Medical School, Ann Arbor, MI, United States.
  • Liu Z; University of Michigan Medical School, Ann Arbor, MI, United States.
  • Wang Z; Department of Bioinformatics, Harbin Medical University, Harbin, Helongjian, China.
  • Zhang X; Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Ye X; Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
  • Handelman SK; Center of Intelligent Medicine, School of Control Science and Engineering, Shandong University, Jinan, Shandong, China.
  • Sexton J; Center of Intelligent Medicine, School of Control Science and Engineering, Shandong University, Jinan, Shandong, China.
  • Eaton K; Department of Biomedical Engineering, Institute of Basic Medical Sciences and School of Basic Medicine, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Higgins G; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital and National Health Commission (NHC) Key Laboratory of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang, Guizhou, China.
  • Omenn GS; Department of Basic Medicine, Guizhou University Medical College, Guiyang, Guizhou, China.
  • Athey B; Department of Respiratory and Critical Care Medicine, Guizhou Provincial People's Hospital and National Health Commission (NHC) Key Laboratory of Immunological Diseases, People's Hospital of Guizhou Province, Guiyang, Guizhou, China.
  • Smith B; Department of Basic Medicine, Guizhou University Medical College, Guiyang, Guizhou, China.
  • Chen L; University of Michigan Medical School, Ann Arbor, MI, United States.
  • He Y; University of Michigan Medical School, Ann Arbor, MI, United States.
Front Immunol ; 13: 1066733, 2022.
Article in English | MEDLINE | ID: covidwho-2288033
ABSTRACT
COVID-19 often manifests with different outcomes in different patients, highlighting the complexity of the host-pathogen interactions involved in manifestations of the disease at the molecular and cellular levels. In this paper, we propose a set of postulates and a framework for systematically understanding complex molecular host-pathogen interaction networks. Specifically, we first propose four host-pathogen interaction (HPI) postulates as the basis for understanding molecular and cellular host-pathogen interactions and their relations to disease outcomes. These four postulates cover the evolutionary dispositions involved in HPIs, the dynamic nature of HPI outcomes, roles that HPI components may occupy leading to such outcomes, and HPI checkpoints that are critical for specific disease outcomes. Based on these postulates, an HPI Postulate and Ontology (HPIPO) framework is proposed to apply interoperable ontologies to systematically model and represent various granular details and knowledge within the scope of the HPI postulates, in a way that will support AI-ready data standardization, sharing, integration, and analysis. As a demonstration, the HPI postulates and the HPIPO framework were applied to study COVID-19 with the Coronavirus Infectious Disease Ontology (CIDO), leading to a novel approach to rational design of drug/vaccine cocktails aimed at interrupting processes occurring at critical host-coronavirus interaction checkpoints. Furthermore, the host-coronavirus protein-protein interactions (PPIs) relevant to COVID-19 were predicted and evaluated based on prior knowledge of curated PPIs and domain-domain interactions, and how such studies can be further explored with the HPI postulates and the HPIPO framework is discussed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.1066733

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.1066733